FBRX - Forte Biosciences Inc
IEX Last Trade
7.93
0.130 1.639%
Share volume: 19,484
Last Updated: Fri 30 Aug 2024 09:00:28 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$7.80
0.13
1.67%
Summary score
28%
Profitability
25%
Dept financing
11%
Liquidity
75%
Performance
24%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-81.11%
Return on assets
-19.23%
Return on sales
-141302.1%
Return on invested capital
248.24%
Total debt ratio
43.2%
Debt ratio change over timeo
0.15%
Current Ratio
4.95%
Quick Ratio
4.95%
Cash Position Ratio
4.77%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-189.03%
Return on assets
-29.06%
Return on sales
-118911.11%
Return on invested capital
427.56%
Total debt ratio
43.26%
Debt ratio change over timeo
-0.8%
Current Ratio
5.01%
Quick Ratio
5.01%
Cash Position Ratio
4.81%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-25.1%
Return on assets
-22.03%
Return on sales
0%
Return on invested capital
392.91%
Total debt ratio
10.61%
Debt ratio change over time
-0.84%
Current Ratio
8.97%
Quick Ratio
8.97%
Cash Position Ratio
8.37%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-197.41%
Return on assets
-145.8%
Return on sales
-514320.02%
Return on invested capital
361.55%
Total debt ratio
15.36%
Debt ratio change over time
0.15%
Current Ratio
14.13%
Quick Ratio
14.13%
Cash Position Ratio
13.42%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | FBRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -81.11% | -3.65% | 12.3% | 6.42% |
| Return on assets | -19.23% | 3.5% | 3.6% | 5.35% |
| Return on sales | -141302.1% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 248.24% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 68% | 60% |
| Total debt ratio | 43.2% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | 0.15% | 224.03% | 6.03% | 1.46% |
| Dept financing | 11% | 50% | 19% | 8% |
| Current Ratio | 5.01% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 5.01% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 4.81% | 1.41% | 0.73% | 1.41% |
| Liquididy | 75% | 18% | 37% | 41% |
| Short-term ratios | FBRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -189.03% | -16.17% | 18.05% | 7.63% |
| Return on assets | -29.06% | 2.71% | 3.58% | 5.03% |
| Return on sales | -118911.11% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 427.56% | 6.54% | 5.97% | 19.39% |
| Profitability | 25% | 34% | 68% | 61% |
| Total debt ratio | 43.26% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -0.8% | 851.68% | 10.97% | 0.58% |
| Dept financing | 11% | 50% | 21% | 8% |
| Current Ratio | 5.01% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 5.01% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 4.81% | 1.41% | 0.73% | 1.41% |
| Liquididy | 75% | 27% | 21% | 39% |